F. Kamali et C. Edwards, CONVERSION OF FLOSEQUINAN TO THE SULFONE METABOLITE IN SUBCELLULAR-FRACTIONS OF HUMAN LIVER, IN-VITRO, Journal of Pharmacy and Pharmacology, 45(6), 1993, pp. 578-580
Flosequinan was metabolized in a NADPH-dependent reaction, by S-oxidat
ion to its principal metabolite, the sulphone. Most of the sulphone me
tabolite was formed within 20 min and reached a plateau by 60 min, fol
lowing incubations of flosequinan (31, 61 or 122 muM) with the microso
mal fraction. Flosequinan was metabolized mainly by the microsomal fra
ction. The S-oxidation of flosequinan in incubations containing mitoch
ondrial and cytosolic fractions was 13 and 5%, respectively, of that d
etected in the microsomal fraction. The route of metabolism of flosequ
inan in-vitro correlates closely with that previously observed in-vivo
. This model could be useful for studying the potential effects of oth
er drugs on flosequinan metabolism in-vitro.